Edwards Lifesciences Corporatio Price Today
Edwards Lifesciences Corporatio
EW
Healthcare
$48.84B
💰
Market Cap
33.4
💸
Price to Earnings
$2.4
🎉
EPS
+81
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
16 |
Strong Buy |
7 |
Hold |
14 |
Sell |
0 |
Strong Sell |
1 |
EW Price Forecast Target
79.5 👉 110.0 +38%
EW EPS Forecast
2.4 👉 2.9 +21%
Financials
Profit Margin
25 %
Revenue Growth
11.4 %
Dividend
$ 0
Held Percent
0.9% - Insiders
85.6% - Institutions
13.5% - Public
Major Fund Holders
-
💰 Blackrock Inc. $4.1B
-
💰 Vanguard Group Inc $4.1B
-
💰 State Street Corporation $2.1B
-
💰 Capital International Investors $2.0B
-
💰 Alliancebernstein L.P. $1.6B
Stock Ideas
Larry Robbins Portfolio
Larry Robbins is a successful hedge fund manager who founded Glenview Capital in 2001 after working as a trader at Omega Advisors. His portfolio strategy has led to impressive returns, with Glenview Capital returning 301% after fees and expenses bet…
Daniel Loeb Portfolio
Daniel Loeb is an American billionaire businessman and founder/CEO of Third Point LLC, a global investment firm managing over $12 billion in assets through long/short equity investments and activism. As one of the world's most successful hedge fund…
Ken Griffin Portfolio
Ken Griffin, the visionary founder of Citadel Investment Group, has transformed portfolio strategy with his innovative and tech-driven approach. Starting as a college student trading stock options, Griffin quickly rose to success and attracted signi…
Warren Buffet Portfolio
Invest like the oracle himself! View the stocks that Warren Buffett holds in the Berkshire Hathaway portfolio.📮FAQ
Some Frequently Asked Questions.
The Edwards Lifesciences Corporatio industry is Medical Devices
The Edwards Lifesciences Corporatio sector is Healthcare
The Edwards Lifesciences Corporatio forecasted predicted Price to Earnings PE ratio is 27.6
The Edwards Lifesciences Corporatio Price to Earnings PE ratio is 33.4
The Market Capitalization of Edwards Lifesciences Corporatio is $48.84B
There are total of 602317391 float shares with 85.6% held by Institutions and 0.9% held by insiders
The MEdwards Lifesciences Corporatio forecasted Earnings per Share EPS is $2.9
The Edwards Lifesciences Corporatio Earnings per Share EPS is 2.4
The Edwards Lifesciences Corporatio company has $4303600000 gross profits with 25 profit margins
The Edwards Lifesciences Corporatio Earnings Growth is -0.231% with -0.244% quarterly earnings growth
The Edwards Lifesciences Corporatio Revenue is $5657099776 with 0.114 revenue growth
The price target for Edwards Lifesciences Corporatio stock is $110.0 for the high target and $75.0 for the low target
The consensus analyst recommendations for Edwards Lifesciences Corporatio is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Edwards Lifesciences Corporatio is Buy, with the following breakdown:
- Buy: 16
- Strong Buy: 7
- Hold: 14
- Sell: 0
- Strong Sell: 1
The Beta of Edwards Lifesciences Corporatio is 1.0
The dividend of Edwards Lifesciences Corporatio is $0
The dividend yield of Edwards Lifesciences Corporatio is 0%
The biggest institutional and mutual fund holders of Edwards Lifesciences Corporatio stock are
- Blackrock Inc.
- Vanguard Group Inc
- State Street Corporation
- Capital International Investors
The Edwards Lifesciences Corporatio ESG Score is 81, with the following breakdown:
- E: 2.86
- S: 8.85
- G: 7.63